凯莱英 港股通 空最新增减持 (2026-04-29) 官网 ( 06821.hk) | 28.41 | 1.75 | 1.49% (1.46%) | 上市时间2021-12-10股价98.85港币涨跌幅-1.10%成交金额8,219.51万港币换手率0.23%市值356.72亿港币H股市值27.51亿港币总股本3.61亿H股本2,783.45万每手股数100上市至今年化投资收益率-18.76%港股通持仓占H股比例44.33% (13.01亿港币2026-04-30) 累计做空占H股比例4.42% (1.22亿港币2026-04-24) | |||
| 所属三级行业药品 (恒生) | 市盈率 | 28.70 | 市净率 | 2.69 | 股息率 | 1.28% (1.25%) | 恒生:医疗保健业药品及生物科技药品 |
| 所属指数指数纳入纳出 | |||||||
| 同股同权 | 查看历史折扣 | ||||||
| 备注 (4): | 双击编辑备注 |
凯莱英(06821) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 孫雪嬌 | Independent Non Executive Director - A/F | 2023-10-18 | -- | |
| 2 | 李家聰 | Independent Non Executive Director | 2021-06-16 | -- | |
| 3 | 張婷 | Non Executive Director | 2021-02-09 | -- | |
| 4 | 王青松 | Independent Non Executive Director | 2019-04-18 | -- | |
| 5 | 張達 | Executive Director | 2018-08-07 | -- | |
| 6 | 張昆 | Independent Non Executive Director - A/F | 2017-01-16 | 2023-10-18 | |
| 7 | HONG Hao | Executive Director | Chairman, CEO | 2011-07-18 | -- |
| 8 | 洪亮 | Executive Director | 2011-07-18 | -- | |
| 9 | SONG Ye | Non Executive Director | 2011-07-18 | -- | |
| 10 | 楊蕊 | Executive Director | 2011-07-18 | -- |